BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 9373708)

  • 21. Clinical value of multiplexed bead-based immunoassays for detection of autoantibodies to nuclear antigens.
    Avaniss-Aghajani E; Berzon S; Sarkissian A
    Clin Vaccine Immunol; 2007 May; 14(5):505-9. PubMed ID: 17376860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison between line immunoassay (LIA) and enzyme-linked immunosorbent assay (ELISA) for the determination of antibodies to extractable nuclear antigenes (ENA) with reference to other laboratory results and clinical features].
    Maclachlan D; Vogt P; Wu X; Rose L; Tyndall A; Hasler P
    Z Rheumatol; 2002 Oct; 61(5):534-44. PubMed ID: 12399881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methods of choice for diagnostic antinuclear antibody (ANA) screening: benefit of adding antigen-specific assays to immunofluorescence microscopy.
    Dahle C; Skogh T; Aberg AK; Jalal A; Olcén P
    J Autoimmun; 2004 May; 22(3):241-8. PubMed ID: 15041045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the indirect immunofluorescence assay as a confirmatory test for detecting antibodies to the human immunodeficiency virus.
    McHugh TM; Stites DP; Casavant CH; Carlson JR; Yee J; McVay PA; Busch MP; Levy JA
    Diagn Immunol; 1986; 4(5):233-40. PubMed ID: 3539456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for antinuclear antibodies by enzyme immunoassay.
    Jaskowski TD; Schroder C; Martins TB; Mouritsen CL; Litwin CM; Hill HR
    Am J Clin Pathol; 1996 Apr; 105(4):468-73. PubMed ID: 8604689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the LIAISON ANA screen assay for antinuclear antibody testing in autoimmune diseases.
    Ghillani P; Rouquette AM; Desgruelles C; Hauguel N; Le Pendeven C; Piette JC; Musset L
    Ann N Y Acad Sci; 2007 Aug; 1109():407-13. PubMed ID: 17785329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicenter evaluation study on a new HEp2 ANA screening enzyme immune assay.
    Bayer PM; Bauerfeind S; Bienvenu J; Fabien N; Frei PC; Gilburd B; Heide KG; Hoier-Madsen M; Meroni PL; Monier JC; Monneret G; Panzeri P; Shoenfeld Y; Spertini F; Wiik A
    J Autoimmun; 1999 Aug; 13(1):89-93. PubMed ID: 10441172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From ANA to ENA: how to proceed?
    Damoiseaux JG; Tervaert JW
    Autoimmun Rev; 2006 Jan; 5(1):10-7. PubMed ID: 16338206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Detection of anti-SSA/Ro antibody by ELISA, double immunodiffusion, and immunoblotting: a comparative study].
    Tong SQ; Shi Q; Wen XH; Gan XD; Shi YP; Zhao Y; Zeng XF; Zhang FC; Dong Y
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2455-7. PubMed ID: 17156670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An immunoenzymatic technique for the detection of antinuclear antibodies].
    Meriche H; Meriche-Gadiri S; Ghaffor M; Abbadi MC
    Ann Biol Clin (Paris); 2000; 58(6):711-4. PubMed ID: 11098167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical significance of antinuclear antibodies in connective tissue disease.
    Pahor A; Krajnc I; Gorenjak M; Holc I
    Wien Klin Wochenschr; 1998 May; 110(9):338-41. PubMed ID: 9629626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of different test systems for simultaneous autoantibody detection in connective tissue diseases.
    Eissfeller P; Sticherling M; Scholz D; Hennig K; Lüttich T; Motz M; Kromminga A
    Ann N Y Acad Sci; 2005 Jun; 1050():327-39. PubMed ID: 16014549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Autoantibodies and peripheral arterial occlusive disease].
    Kroeger K; Kreuzfelder E
    Herz; 2004 Feb; 29(1):26-31. PubMed ID: 14968339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased percentages of autoantibodies in immunoglobulin A-deficient children do not correlate with clinical manifestations.
    Gulez N; Karaca NE; Aksu G; Kutukculer N
    Autoimmunity; 2009 Jan; 42(1):74-9. PubMed ID: 19127458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Autoantibodies].
    Ishihara Y
    Rinsho Byori; 2005 Jun; 53(6):562-9. PubMed ID: 16026086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of three commercially available enzyme immunoassays for the screening of autoantibodies to extractable nuclear antigens.
    Jaskowski TD; Schroder C; Martins TB; Mouritsen L; Hill HR
    J Clin Lab Anal; 1995; 9(3):166-72. PubMed ID: 7602423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
    Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
    J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario.
    Sebastian W; Roy A; Kini U; Mullick S
    Indian J Pathol Microbiol; 2010; 53(3):427-32. PubMed ID: 20699497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Assessment methods of autoantibodies in autoimmune diseases].
    Zabek J
    Przegl Epidemiol; 2002; 56 Suppl 4():59-66. PubMed ID: 14750264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Detection of anti-nuclear antibodies in liver diseases by indirect immunofluorescence method and enzyme-linked immunosorbent assay].
    Koizumi H; Onozuka Y; Shibata M; Sano K; Oosima Y; Miyachi K; Ueno Y
    Rinsho Byori; 1999 Aug; 47(8):744-8. PubMed ID: 10511806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.